By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The Redefining Early Stage Investments (RESI) San Francisco 2023 Innovator’s Pitch Challenge (IPC) application is now open!
RESI Boston saw nearly 60 early-stage companies across therapeutics, medical devices, diagnostics, digital health pitch in front of judging panels of investors and industry experts, accompanied by a full audience with standing room only. Each finalist company also prepares a posterboard to be showcased in the exhibit hall and competes for “RESI Cash” which attendees use to “invest” in their favorite presenters for the final prizes.
RESI JPM San Francisco is the biggest conference of the year, attracting nearly 1,200 attendees, and we are thrilled to return to an in-person format for the first time in three years. Participating in the IPC is a great way to boost your visibility and receive valuable feedback from investors and strategic partners. Do not miss out on the opportunity to pitch at one of the largest RESIs of the year, during the life science industry’s busiest week!
The deadline to apply is Wednesday, November 30, but we expect slots to fill very quickly and highly encourage early application submissions!
Next Phase Newsletter 
Leave a comment